Status:
COMPLETED
Aloe Vera in Irritable Bowel Syndrome
Lead Sponsor:
Sahlgrenska University Hospital
Collaborating Sponsors:
Calmino group AB
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of the present study is to study the effect of aloe vera in the treatment of IBS patients in a randomized, double-blind placebo controlled study.
Detailed Description
There is limited knowledge of the IBS pathophysiology, absence of biological markers and therefore few effective treatment options. IBS therefore contributes to difficulties in the management of the p...
Eligibility Criteria
Inclusion
- IBS according to the Rome III criteria
- Adults
Exclusion
- other GI disorders
- other medical conditions
- were pregnancy or breast-feeding
- food allergy or intolerance to other than lactose
- ongoing intake of aloe vera products
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT01400048
Start Date
January 1 2010
End Date
March 1 2017
Last Update
September 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mag-tarmlab, Dept of Internal Medicine, Sahlgrenska University Hospital
Gothenburg, Sweden, 413 45